Meta-Analysis of the Efficacy of Methylphenidate for Treating Adult Attention-Deficit/Hyperactivity Disorder

Journal of Clinical Psychopharmacology

Volumn 24, Issue 1, 2004, Pages 24-29

  Faraone, Stephen V ^a,b,c   Spencer, Thomas ^a,b   Aleardi, Megan ^a   Pagano, Christine ^a   Biederman, Joseph ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPHENIDATE; PLACEBO;

ADULTHOOD; ATTENTION DEFICIT DISORDER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG MEGADOSE; HUMAN; META ANALYSIS; METHODOLOGY; PHYSICIAN; PRIORITY JOURNAL; PUBLICATION; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; REVIEW; SELF CONCEPT; TREATMENT OUTCOME;

ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; HUMANS; METHYLPHENIDATE; TREATMENT OUTCOME;

EID: 1642457280     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jcp.0000108984.11879.95     Document Type: Review

References (40)

1. Barkley RA, ed. Attention Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatment. New York: Guilford Press; 1998.
2. Faraone SV, Sergeant J, Gillberg C, et al. The worldwide prevalence of ADHD: is it an American condition? World Psychiatry. 2003;2: 104-113.
3. Greenhill LL, Pliszka S, Dulcan MK, et al. Summary of the practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults. J Am Acad Child Adolesc Psychiatry. 2001;40:1352-1355.
4. Schachter HM, Pham B, King J, et al. How efficacious and safe is short-acting methylphenidate for the treatment of attention-deficit disorder in children and adolescents? A meta-analysis. CMAJ. 2001; 165:1475-1488.
5. Smith BH, Waschbusch DA, Willoughby MT, et al. The efficacy, safety, and practicality of treatments for adolescents with attention-deficit/hyperactivity disorder (ADHD). Clin Child Fam Psychol Rev. 2000; 3:243-267.
6. Greenhill L, Beyer DH, Finkleson J, et al. Guidelines and algorithms for the use of methylphenidate in children with attention-deficit/hyperactivity disorder. J Attent Disord. 2002;6:89-100.
7. Pliszka SR, Greenhill LL, Crismon ML, et al. The Texas Children's Medication Algorithm Project: report of the Texas Consensus Conference Panel on medication treatment of childhood attention-deficit/hyperactivity disorder. Part II: Tactics. Attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2000;39: 920-927.
8. Greenhill LL, Pliszka S, Dulcan MK, et al. Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults. J Am Acad Child Adolesc Psychiatry. 2002;41:26S-49S.
9. Dulcan M. Practice parameters for the assessment and treatment of children, adolescents, and adults with attention-deficit/hyperactivity disorder. American Academy of Child and Adolescent Psychiatry. J Am Acad Child Adolesc Psychiatry. 1997;36:85S-121S.
10. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177-188.
11. Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629-634.
12. Huber PJ. The behavior of maximum likelihood estimates under non-standard conditions. Proc 5th Berkeley Symp Math Stat Prob. 1967; 1:221-233.
13. Stata Corporation ed. Stata User's Guide: Release 7.0. College Station, TX: Stata Corporation; 2001.
14. Mattes JA, Boswell L, Oliver H. Methylphenidate effects on symptoms of attention deficit disorder in adults. Arch Gen Psychiatry. 1984; 41:1059-1063.
15. Wender PH, Reimherr FW, Wood DR, et al. A controlled study of methylphenidate in the treatment of attention deficit disorder, residual type, in adults. Am J Psychiatry. 1985;142:547-552.
16. Gualtieri CT, Ondrusek MG, Finley C. Attention deficit disorders in adults. Clin Neuropharmacol. 1985;8:343-356.
17. Spencer T, Wilens T, Biederman J, et al. A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood-onset attention-deficit hyperactivity disorder. Arch Gen Psychiatry. 1995;52:434-443.
18. Spencer TJ, Biederman J. Efficacy in a 6-Month Trial of Methylphenidate in Adults With ADHD. Scientific Proceedings of the 49th Annual Meeting: American Academy of Child and Adolescent Psychiatry. San Francisco, CA:AACAP; 2002.
19. Kuperman S, Perry PJ, Gaffney G, et al. Bupropion SR vs. methylphenidate vs. placebo for attention deficit hyperactivity disorder in adults. Ann Clin Psychiatry. 2001;13:129-134.
20. Cohen J. Statistical Power Analysis for the Behavioral Sciences. New York: Academic Press; 1988.
21. Shekim WO, Asamow RF, Hess E, et al. A clinical and demographic profile of a sample of adults with attention deficit hyperactivity disorder, residual state. Compr Psychiatry. 1990;31:416-425.
22. Levin FR, Evans SM, McDowell DM, et al. Methylphenidate treatment for cocaine abusers with adult attention-deficit/hyperactivity disorder: a pilot study. J Clin Psychiatry. 1998;59:300-305.
23. Wood DR, Reimherr FW, Wender PH, et al. Diagnosis and treatment of minimal brain dysfunction in adults: a preliminary report. Arch Gen Psychiatry. 1976;33:1453-1460.
24. Iaboni F, Bouffard R, Minde K, et al. The efficacy of methylphenidate in treating adults with attention-deficit/hyperactivity disorder. Philadelphia, PA: American Academy of Child and Adolescent Psychiatry; 1996.
25. Adler LA, Chua HC. Management of ADHD in Adults. J Clin Psychiatry. 2002;63:29-35.
26. Murphy P, Schachar R. Use of self-ratings in the assessment of symptoms of attention deficit hyperactivity disorder in adults. Am J Psychiatry. 2000;157:1156-1159.
27. Biederman J, Faraone SV, Knee D, et al. Retrospective assessment of DSM-III attention deficit disorder in non-referred individuals. J Clin Psychiatry. 1990;51:102-106.
28. Faraone SV, Biederman J, Feighner JA, et al. Assessing symptoms of attention deficit hyperactivity disorder in children and adults: which is more valid? J Consult Clin Psychol. 2000;68:830-842.
29. Mannuzza S, Klein RG, Klein DF, et al. Accuracy of adult recall of childhood attention deficit hyperactivity disorder. Am J Psychiatry. 2002;159:1882-1888.
30. Shaffer D. Attention deficit hyperactivity disorder in adults. Am J Psychiatry. 1994;151:633-638.
31. Faraone SV, Spencer T, Montano CB, et al. Attention deficit hyperactivity disorder in adults: a survey of current practice in psychiatry and primary care. Arch Intern Med. In press.
32. The MTA Cooperative Group. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal treatment study of children with ADHD [see comments]. Arch Gen Psychiatry. 1999;56:1073-1086.
33. Michelson D, Adler L, Spencer T, et al. Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies. Biol Psychiatry. 2003;53:112-120.
34. Spencer T, Biederman J, Wilens T, et al. Efficacy of a mixed amphetamine salts compound in adults with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry. 2001;58:775-782.
35. Wilens TE, Biederman JB, Mick E, et al. A systematic assessment of tricyclic antidepressants in the treatment of adult attention-deficit hyperactivity disorder. J Nerv Ment Dis. 1995;183:48-50.
36. Wilens TE, Biederman J, Prince J, et al. Six-week, double-blind, placebo-controlled study of desipramine for adult attention deficit hyperactivity disorder. Am J Psychiatry. 1996;153:1147-1153.
37. Spencer T, Biederman J, Wilens T, et al. Effectiveness and tolerability of tomoxetine in adults with attention deficit hyperactivity disorder. Am J Psychiatry. 1998;155:693-695.
38. Wilens TE, Spencer TJ, Biederman J, et al. A controlled clinical trial of bupropion for attention deficit hyperactivity disorder in adults. Am J Psychiatry. 2001;158:282-288.
39. Riggs P, Leon S, Mikulich S, et al. An open trial of buproprion for ADHD in adolescents with substance use disorder and conduct disorder. J Am Acad Child Adolesc Psychiatry. 1998;37:1271-1278.
40. Wilens T, Spencer T, Biederman J. A review of the pharmacotherapy of adults with attention-deficit/hyperactivity disorder. J Attent Disord. 2002;5:189-202.